1-3
2026
影响因子区间
190天
平台估算
17%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity.JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered.Under no circumstances does the journal guarantee publication before the editorial board makes its final decision.The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.
【译文】《医学真菌杂志》/《医学真菌学杂志》(JMM)用英文发表关于人类和动物真菌学的研究成果。主要关注临床、诊断、流行病学、免疫学、医学、病理学、预防或治疗方面的真菌病。还涵盖与形态学(电子和光子显微镜)、生理学、生物化学、细胞和分子生物学、免疫化学、遗传学、分类或系统发育有关的基本方面,这些方面主要与人类或动物中的致病真菌和放线菌有关。对于显示对致病真菌有抑制活性的天然产物的研究,如果没有化学特征和抑制活性化合物的鉴定,则不能考虑。JMM发表(特邀)社论、原创文章、综述(和迷你综述)、病例报告、技术笔记、编辑信件和信息。只有具有真正原创性(新物种、新的临床表现、新的地理分布等)且完全有文件证明(鉴定方法、结果等)的临床病例才会被考虑。在任何情况下,该杂志都不会在编辑委员会做出最终决定之前保证发表。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |